Reverse microdialysis of 5-HT (2 mM) or the 5-HT4R agonist ML10302 (400 nM) induces cAMP production in the brains of AD mouse models, subsequently activating PKA and the downstream mitogen-activated protein-ERK kinase (MEK)/ERK pathway. Here, MAP2K7 is linked to Alzheimer disease.